GSK’s breast cancer drug Tykerb fails in gastric cancer study
GlaxoSmithKline’s (GSK) intentions to expand the indication of personalised cancer drug Tyverb/ Tykerb took a blow when it failed to hit its... Read More
Immunotherapy is not just for melanoma anymore
A new class of drugs are showing to be effective in clinical trials – immunotherapies. They were high on the list of... Read More
Gastric Cancer with Epstein-Barr Virus Is Less Deadly
In a small but significant percentage (9%) of gastric cancers, tumor cells contain Epstein-Barr virus (EBV). To assess whether EBV positivity is... Read More
Does salt contribute to gastric cancer? Questions arise…
Are Americans getting mixed messages about how much sodium they should be consuming? Lately, yes, and some of those messages are muddled... Read More
Breath Test for Stomach Cancer
A new method for diagnosing gastric cancer via breath samples can help distinguish between cancer and other gastric ailments such as ulcers... Read More
Bayer wins new use for fast-moving cancer drug Stivarga
Bayer’s new cancer drug Stivarga has already added a notch to its belt. Cleared by the FDA last year to treat colorectal... Read More
Treatment Advances Reported for Gastrointestinal Cancers
Prior to the 10th annual Gastrointestinal Cancers Symposium, being held January 24-26, 2013 in San Francisco, CA, a January 22 press cast... Read More
Epigenetic analysis of stomach cancer finds new disease subtypes
Researchers at the Duke-NUS Graduate Medical School in Singapore have identified numerous new subtypes of gastric cancer that are triggered by environmental... Read More
New Test of “Smart Bomb” Drug: A Study of Trastuzumab Emtansine Versus Taxane in Patients With Advanced Gastric Cancer
GCF board member Dr. James Ford will be managing the Northern California trial site for a major international study in gastric cancer... Read More
Positive Results For Ramucirumab as Single Agent in Phase III Gastric Cancer Trial
Eli Lilly announced that the REGARD trial, a Phase III study of ramucirumab (IMC-1121B) in patients with metastatic gastric cancer, met its... Read More
